A coalition of organisations linked to the US hemp market has released the first part of a series of policy recommendations – while one CBD firm has been referred to the US Federal Trade Commission over extravagant health claims
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields